Procter & Gamble reported Q1/26 revenue of $20.8 billion, up 3% year-over-year, while adjusted EPS rose 21% to $1.78. Management maintained guidance for low-to-mid single-digit top-line growth and mid-teens EPS growth for the full year. Despite a wide economic moat and consistent free cash flow generation of $13.5 billion over the past twelve months, the shares trade at 20.5x forward earnings and 23x free cash flow, above the company’s projected growth runway. Analysts estimate intrinsic value at $122.63 per share, leading most sell-side strategists to maintain a Hold rating as the stock currently trades slightly above that threshold.

The stock fell to a 52-week low of $137.62 on Monday before recovering modestly to $138.04 at yesterday’s close. This volatility reflects soft consumer demand in key categories such as beauty and home care, escalating promotional intensity that has pressured gross margins by 70 basis points year-to-date, and a challenging macroeconomic backdrop across North America and Europe. Trading volumes spiked 35% on the day of the low, signaling both pent-up selling interest and opportunistic buying by value-oriented funds.

In response to concerns raised by the Texas Attorney General regarding fluoride concentrations in Crest Kids toothpaste, Procter & Gamble has unveiled new packaging emphasizing proper dosage and age-appropriate usage. The revised cartons feature child-proof seals and clearer labeling on fluoride content per application, backed by a national marketing campaign rolling out this quarter. P&G expects the packaging changes to incur incremental one-time costs of $45 million but anticipates mitigating legal and reputational risks while safeguarding market share in the $850 million U.S. children’s oral care segment.